Press releases
- Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
- Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
- Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
- Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Key statistics
As of last trade Surmodics Inc (SU6:BER) traded at 38.20, -0.52% below its 52-week high of 38.40, set on Jun 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.20 |
---|---|
High | 38.20 |
Low | 38.20 |
Bid | 38.40 |
Offer | 40.00 |
Previous close | 38.40 |
Average volume | 0.00 |
---|---|
Shares outstanding | 14.26m |
Free float | 13.73m |
P/E (TTM) | 43.71 |
Market cap | 598.27m USD |
EPS (TTM) | 0.9597 USD |
Data delayed at least 15 minutes, as of Jun 18 2024 07:08 BST.
More ▼